Ketamine Enhances Analgesia and Mood in Chronic Pain Patients
Key facts
- Where
- Surrey, CanadaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 20 and 99 years old?
Source: NCT05985811, who can take part
Where in Canada
- Salem Anaesthesia Pain ClinicSurrey, CanadaContact: Olumuyiwa Bamgbade, MD, FRCPCTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Salem Anaesthesia Pain Clinic
- Trial code
- NCT05985811
- Record updated
- 27 January 2025
- Original description
Most chronic pain patients have mood disorders. The mood disorders may improve with better analgesia produced by Ketamine injections. A prospective study of patients undergoing interventional pain therapy using Ketamine injections. Pre-injection and post-injection patient data is collected. Pain is measured using numeric pain rating scale, and change in pain score by 2-points is considered significant. Sleep is measured using Likert sleep scale, and change in sleep score by 2-points is considered significant. Anxiety is measured using general anxiety disorder (GAD-7) scale, and change in anxiety score by 4-points is considered significant. Depression is measured using patient health questionnaire (PHQ-9), and change in depression score by 5-points is considered significant.Read full original descriptionShow less
Ketamine Analgesia Enhances Functional Quality and Mood in Chronic Pain Patients
Most chronic pain patients have mood disorders. The mood disorders may improve with better analgesia produced by Ketamine injections. A prospective study of patients undergoing interventional pain therapy using Ketamine injections. Pre-injection and post-injection patient data is collected. Pain is measured using numeric pain rating scale, and change in pain score by 2-points is considered significant. Sleep is measured using Likert sleep scale, and change in sleep score by 2-points is considered significant. Anxiety is measured using general anxiety disorder (GAD-7) scale, and change in anxiety score by 4-points is considered significant. Depression is measured using patient health questionnaire (PHQ-9), and change in depression score by 5-points is considered significant.
Inclusion: adult chronic pain patients; associated mood disorder; good treatment compliance; associated chronic insomnia; regular ketamine pain therapy injection; consent for clinical record quality assurance review.
Exclusion: lack of ketamine pain therapy injection; severe cognitive disorder; major neuropsychiatric disorder; inability to provide consent; cannabis use; stimulant use; substance abuse; poor treatment compliance.